Insights into Company Bills & Payments

Mangalam Cement Ltd ↗

📍 Kota, West Bengal, India Active NSE MANGLMCEM CIN L26943RJ1976PLC001705 Cement, Building Materials & Polymers
Search companies

Key Metrics of Mangalam Cement Ltd

Revenue₹1,758 Cr▲ 4.6% YoYFY 2025-26
EBITDA₹239 Cr▲ 9.6% YoY
Net profit₹129 Cr▲ 186.2% YoY
Net worth₹977 Cr▲ 14.7% YoY
Competitors10identified

About Mangalam Cement Ltd

Sectors

Cement, Building Materials & PolymersCement

Company details

Website
mangalamcement.com
Registered office
Aditya Nagar, Morak Distt, Kota, In-rj, 326520
Listed
NSE: MANGLMCEM · ₹887.85

Operational Areas of Mangalam Cement Ltd

Cement, Building Materials & Polymers›Cement

Company summary

Entity details

CINL26943RJ1976PLC001705
LEI code335800AOA8ALSHZKN243
State codeRJ
PIN code326520
Current legal nameMANGALAM CEMENT LTD
Classification—
Listing statusListed (NSE: MANGLMCEM)
Registration no.001705
Company age—
PAN—
CountryIndia
CityKota
StateWest Bengal
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code26943
Description of main activityManufacture of other non-metallic mineral products (cement, glass, ceramics)
Description of business activityManufacture of other non-metallic mineral products (cement, glass, ceramics)
SectorCement, Building Materials & Polymers · Cement

Share price · NSE: MANGLMCEM

MANGLMCEM on NSE

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 1 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 31 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 26 Mar 2026 CARE A+ Stable outlook · Short term A1+ · Reaffirmed
Change in last 12 monthsNo change
Change since first rating on record▼ 1 notchsince Apr 2018
Rating actions110 up · 0 down
Liquidity (CARE)Adequate

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
26 Mar 2026CAREReaffirmed A+A1+Stable₹1,163 Cr View
03 Apr 2025CAREReaffirmed A+A1+Stable₹1,127 Cr View
19 Mar 2024CAREReaffirmed A+A1+Stable₹1,090 Cr View
28 Mar 2023CAREReaffirmed A+A1+Stable₹1,044 Cr View
07 Apr 2022CAREReaffirmed A+A1+Stable₹866 Cr View
07 Mar 2022CAREReaffirmed A+A1+Stable₹75.0 Cr View
31 Dec 2020CAREReaffirmed (from A+) A+A1+Stable₹2,031 Cr View
23 Dec 2019CAREReaffirmed A+A1Stable₹865 Cr View
19 Feb 2019CAREReaffirmed A+A1Stable₹742 Cr View
10 Aug 2018CARERevised (from AA) A+A1Stable₹1,437 Cr View
06 Apr 2018CAREOther AA-—Stable₹250 Cr View

Credit strengths (CARE, Mar 2026)

+ Established brand with concentration in the northern region and favourable sales mix

MCL was incorporated in 1976 and commenced its business in 1977. The company sells cement under the brand name ‘Birla Uttam Cement’ and ‘Mangalam ProMaxX’, which is well recognised majorly in the northern and central markets. Going forward, CareEdge Ratings expects the demand in the northern and the central regions to be healthy from rural housing and infra projects, especially in Uttar Pradesh on the back of government spending and a pick-up in construction. The company produces two grades

+ Healthy operational performance amidst market-driven challenges

In FY25, the company reported a TOI of ₹1,681 crore (FY24: ₹1,727 crore), reflecting a marginal 3% Y-o-Y decline. While volumes improved to 3.50 MT (FY24: 3.37 MT), realisations moderated to ₹4,800 per tonne (FY24: ₹5,120 per tonne), largely due to industry-wide demand slowdown, which led to subdued construction activity and pricing pressure across key markets. However, the capacity utilisation remained robust at 80% in FY25 (PY: 77%) above the industry’s average.

+ Adequate backward integration and cost optimisation

MCL has a captive limestone mine situated in proximity to the plant which meets almost 90% of the total limestone requirement of the company. Proximity to the major raw material source minimises the transportation cost for sourcing of raw materials and enhances the operational effectiveness. The captive mines have sufficient proven reserves of ~152 million tonnes. The company mixes the captive limestone from Morak mines with high-grade limestone which is partially procured from its captive mine

+ Financial risk profile expected to remain adequate despite of largely debt-funded capex plans

The capital structure remained moderate with overall gearing of 0.74x as on March 31, 2025. However, net debt/PBILDT increased to 2.66x (FY24: 1.91x), driven by higher working capital borrowings and moderation in profitability across the industry due t o weak volume growth and declining realisations. Going forward, the company is undertaking capacity expansioni.e. the Aligarh unit expansion, which is nearing completion as of

Credit challenges

− Exposure of MCL to competitive pressure given its geographical concentration and moderate scale of operation

The company operates majorly in Rajasthan, Uttar Pradesh, and Madhya Pradesh. The company is exposed to competitive pressure from larger players who operate in these states due its moderate scale of operations. Exposure to volatility in input costs and cyclicality in the sector The company is exposed to the commodity price risk arising out of fluctuation in prices of raw materials (gypsum, iron ore, fly ash, and iron slag) and fuel (coal and pet coke). Coal (indigenous and international) is used

− Exposure to volatility in input costs and cyclicality in the sector

The company is exposed to the commodity price risk arising out of fluctuation in prices of raw materials (gypsum, iron ore, fly ash, and iron slag) and fuel (coal and pet coke). Coal (indigenous and international) is used for both the power generation to run its plants and as fuel for kilns. While pet coke is mostly imported, for coal, the company is relying on both domestic and international sources. Going forward, the company is expected to continue its focus on improving its internal efficien

Could lead to an upgrade

• Increase in scale of operation (total operating income [TOI] greater than ₹2,000 crore) and profitability (PBILDT margin greater than 18%) leading to improvement in debt protection metrics (PBILDT interest coverage greater than 5.0x) on a sustained basis.

Could lead to a downgrade

• Lower-than-envisaged profitability or higher-than-envisaged debt-funded capital expenditure (capex) leading to a net debt/ PBILDT above 3.6x on a sustained basis.

Agency-reported financials (CARE, 26 Mar 2026)

MetricMarch 31, 2024March 31, 20259MFY26
Total operating income₹1,728 Cr₹1,681 Cr₹1,296 Cr
PBILDT*₹205 Cr₹163 Cr₹163 Cr
Profit after tax (PAT)₹59.72 Cr₹45.06 Cr₹63.72 Cr
Overall gearing (x)0.76×0.74×—
Interest coverage (x)3.04×2.36×4.00×
Revenue growth (YoY)—−2.7%—
PAT margin3.5%2.7%4.9%

Borrowings & rated debt

Rated borrowing limits (latest)₹1,163 Cr
Peak rated limits₹2,031 CrDec 2020 · CARE
Limits raised0 times1 new facility rated

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Long-term bank facilitiesWorking capital & bank lines—₹478 Cr— A+ (Stable)ReaffirmedCARE
Long-term Short-term bank facilitiesWorking capital & bank lines—₹535 Cr— A+ / A1+ (Stable)ReaffirmedCARE
Short-term bank facilitiesWorking capital & bank lines—₹75.0 Cr— A1+ReaffirmedCARE
Commercial paperCommercial paper—₹75.0 Cr— A1+ReaffirmedCARE

CARE ratings on record (checked 23 Oct 2026)

InstrumentAmountRating
BG/LC₹535 CrCARE A+; Stable / CARE A1+
Cash Credit₹230 CrCARE A+; Stable
Commercial Paper (Standalone)₹75.0 CrCARE A1+
Long Term₹190 CrCARE A+; Stable
Non Convertible Debentures—Withdrawn
Term Loan₹58.7 CrCARE A+; Stable
Working Capital Demand loan₹75.0 CrCARE A1+

Lenders

Fund-based - LTCash CreditAxis Bank Ltd.
Fund-based - LTCash CreditHDFC Bank Ltd.
Fund-based - LTCash CreditICICI Bank Ltd.
Fund-based - LTCash CreditIndusInd Bank Ltd.
Fund-based - LTCash CreditState Bank of India
Fund-based - LTTerm LoanHDFC Bank Ltd.
Fund-based - STWorking Capital Demand loanIDFC First Bank Ltd.
Fund-based - STWorking Capital Demand loanIndusInd Bank Ltd.
Non-fund-based - LT/ STBG/LCDBS Bank India Ltd.
Non-fund-based - LT/ STBG/LCHDFC Bank Ltd.
Non-fund-based - LT/ STBG/LCICICI Bank Ltd.
Non-fund-based - LT/ STBG/LCIDFC ltd
Non-fund-based - LT/ STBG/LCIndusInd Bank Ltd.
Non-fund-based - LT/ STBG/LCRBL Bank Limited
Non-fund-based - LT/ STBG/LCState Bank of India
Non-fund-based - LT/ STBG/LCYes Bank Ltd.
Term LoanLong TermAxis Bank Ltd.
Term LoanLong TermICICI Bank Ltd.
Term LoanLong TermIDFC First Bank Ltd.
Term LoanLong TermIndusInd Bank Ltd.

Credit assessment · Cement

CARE Ratings’ Criteria for Rating Cement Companies (Sep 2024) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityPoorAgency: Adequate
DirectionStableAgency outlook: Stable
CARE rating · Mar 2026A+1 notch above indicative

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Next action stable or better (model)58%
Information on file89% · missing: Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further bank funding difficult Next rating action stable or better: 58% (At risk of downgrade) · ML model on 4072 rating histories, AUC 0.666
Rated limits₹1,163 Cr
Not yet allocated—
Extra debt within 3.5× EBITDA—
Interest coverage4.00×
Limit utilisation86%
Open bank charges0 · —
  • Credit outlook model: 58% chance the next rating action is stable or better
  • Current rating A+ (investment grade)
  • Interest coverage 4×
  • Working-capital limits 86% utilised on average

What happened, step by step

Refinanced bank debt with new funding from Axis Finance Limited
  1. Dec 2020 — ₹75 cr raised from Axis Finance Limited
  2. Dec 2020 — Full repayment of debt

“As per discussion with the management, the company plans to raise Rs.150 crores by January 2021 in addition to Rs.75 crores raised in September 2020 from Axis Finance Limited.”

Capex funded with bank debt
  1. Dec 2019 — Term debt tied up
  2. Dec 2020 — Project / plant of ₹135 cr

“Out of the total debt of Rs.225 crores, the company will use Rs.100 crore to finance the clinker expansion project (total cost of ~Rs.135 crores, where Rs.35 crores will be finance through internal accruals).”

Rated limits by facility

Timeline

26 Mar 2026 CARE reaffirmed: A+ (Stable)Rated limits ₹1,163.41 cr CARE rationale
26 Mar 2026 Cash & liquid funds ₹9.47 cr
From the report

As on December 31, 2025, the company maintained total liquid balances of ₹240.47 crore, including fixed deposits of ₹162.57 crore, mutual fund investments of ₹68.43 crore, and cash balance of ₹9.47 crore.

CARE rationale
26 Mar 2026 Debt repayments due in 2026: ₹12.81 cr
From the report

Against this, the company has modest near-term repayment obligations of ₹12.81 crore due in February and March 2026, having already repaid ₹58.7 crore till January 31, 2026.

CARE rationale
26 Mar 2026 Average working-capital utilisation 86%
From the report

In the last 12 months ended December 2025, the average fund-based working capital utilisation stood at 86%.

CARE rationale
03 Apr 2025 CARE reaffirmed: A+ (Stable)Rated limits ₹1,127.35 cr CARE rationale
03 Apr 2025 Cash & liquid funds ₹156 cr
From the report

Liquidity: Adequate The liquidity position of MCL is adequate with gross cash accruals of ₹156 crore in FY24 and ₹92 crore in 9MFY25.

CARE rationale
03 Apr 2025 Debt repayments due in FY25: ₹21 cr
From the report

As against these, the company has balance repayment obligations of ₹21 crore in FY25 while the scheduled repayments for FY26 and FY27 in the range of ₹65-90 crore, respectively.

CARE rationale
03 Apr 2025 Average working-capital utilisation 84%
From the report

The past 12 months, average fund-based working capital utilisation of MCL ended December 2024 stood at 84%.

CARE rationale
19 Mar 2024 CARE reaffirmed: A+ (Stable)Rated limits ₹1,090.31 cr CARE rationale
19 Mar 2024 Full repayment of term debt
From the report

Going forward, it is expected that the gearing levels will further decline with no major debt-funded capex planned and gradual repayment of term debt.

CARE rationale
19 Mar 2024 Cash & liquid funds ₹98 cr
From the report

Liquidity: Adequate The liquidity position of MCL remains adequate marked by gross cash accruals of ₹98 crore and cash and cash equivalents of ₹218.92 crore as on December 31, 2023.

CARE rationale
19 Mar 2024 Debt repayments due in FY24: ₹80 cr
From the report

As against these, the company had total repayment obligations of around ₹80 crore in FY24 out of which only ₹15 crore remains for Q4FY24.

CARE rationale
28 Mar 2023 CARE reaffirmed: A+ (Stable)Rated limits ₹1,043.64 cr CARE rationale
28 Mar 2023 Full repayment of term debt
From the report

Going forward, the management guidance is that the gearing levels are expected to decline with no major debt funded capex planned and gradual repayment of term debt.

CARE rationale
28 Mar 2023 Debt repayments due in 2023: ₹52 cr
From the report

However, the accruals generated during 9MFY23 along with the existing liquid balance with MCL remained sufficient to meet the schedule d debt repayment obligation of ₹52 crore until January 31, 2023.

CARE rationale
28 Mar 2023 Debt repayments due in FY24: ₹85 cr
From the report

Going forward, with moderation witnessed in the input cost and steps taken by to improve its operating efficiency, MCL is expected to generate sufficient accruals to meet its debt repayment obligations of ₹85 crore and ₹90 crore in FY24 and FY25 respectively.

CARE rationale
07 Apr 2022 CARE reaffirmed: A+ (Stable)Rated limits ₹866.09 cr CARE rationale
07 Apr 2022 Full repayment of term debt
From the report

Going forward, the management guidance is that the gearing levels are expected to decline with no major debt funded capex planned and gradual repayment of term debt.

CARE rationale
07 Apr 2022 Cash & liquid funds ₹198 cr
From the report

Liquidity -Strong The liquidity position of MCL is adequate with gross cash accruals of Rs.198 cr in FY21 and Rs.106 crin 9MFY22.

CARE rationale
07 Apr 2022 Average working-capital utilisation 71%
From the report

The average fund based utilization of MCL in last 12 months has been at 71% (PY: 78%) with unutilized line of credit standing at ~Rs.43 crore as on Dec 31, 2021.As part of the liquidity policy, the management keeps liquid balances at all times to meet contingencies.

CARE rationale
07 Mar 2022 CARE reaffirmed: A+ (Stable)Rated limits ₹75 cr CARE rationale
07 Mar 2022 Full repayment of term debt
From the report

Going forward, the manage ment guidance is that the gearing levels are expected to decline with no major debt funded capex planned and gradual repayment of term debt.

CARE rationale
07 Mar 2022 Cash & liquid funds ₹198 cr
From the report

Liquidity -Strong The liquidity position of MCL is adequate with gross cash accruals of Rs.198 cr in FY21 and Rs.106cr in 9MFY22.

CARE rationale
07 Mar 2022 Average working-capital utilisation 71%
From the report

The average fund based utilization of MCL in last 12 months has been at 71% (PY: 78%) with unutilized line of credit 3 CARE Ratings Ltd.

CARE rationale
31 Dec 2020 CARE reaffirmed: A+ (Stable)Rated limits ₹2,031.12 cr CARE rationale
31 Dec 2020 ₹75 cr raised from Axis Finance Limited
From the report

As per discussion with the management, the company plans to raise Rs.150 crores by January 2021 in addition to Rs.75 crores raised in September 2020 from Axis Finance Limited.

CARE rationale
31 Dec 2020 Capex / project: ₹135 cr
From the report

Out of the total debt of Rs.225 crores, the company will use Rs.100 crore to finance the clinker expansion project (total cost of ~Rs.135 crores, where Rs.35 crores will be finance through internal accruals).

CARE rationale
31 Dec 2020 Debt repayments due in FY22: ₹102 cr
From the report

Since the repayment of the new loans are of longer tenure (Rs.50 crores for 5 years and Rs.100 crores for 10 years), the repayment obligation for FY22 is expected to reduce to Rs.69.92 crores and Rs.68.86 crores for FY23 as against current repayment obligation of Rs.102 crores in FY22 and Rs.119 crores in FY23 respectively.

CARE rationale
31 Dec 2020 Full repayment of debt (₹225 cr)
From the report

Out of the Rs.225 crores received, Rs.100 crores will be used for Capex funding and the rest will be utilized for prepayment of debts.

CARE rationale
31 Dec 2020 Average working-capital utilisation 78%
From the report

The average fund based utilization of MCL in last 12 months has been at 78% with unutilized line of credit standing at ~Rs.60 crore as on Nov 30, 2020.

CARE rationale
31 Dec 2020 Cash & liquid funds ₹158.6 cr
From the report

Liquidity of the company is also bolstered by liquid in vestment/unencumbered cash & bank balance stood at Rs.158.60 crore as on Nov 30, 2020.

CARE rationale
23 Dec 2019 CARE reaffirmed: A+ (Stable)Rated limits ₹864.64 cr CARE rationale
23 Dec 2019 Debt repayments due in FY19: ₹91.66 cr
From the report

The company earned a GCA of Rs.30.54 crore in FY19 (Rs.63.20 crore in FY18) crore against a debt repayment obligation of Rs.91.66 crore in FY19.

CARE rationale
23 Dec 2019 New borrowing arranged (term loans)
From the report

The shortfall in repayment was met out of new term loans availed by the company during FY19.

CARE rationale
23 Dec 2019 Debt repayments due: ₹111.94 cr
From the report

In FY20, GCA is expected to be sufficient to meet the debt repayment obligations of Rs.111.94 crore (about Rs.98 cr has already been repaid as on 26th November 2019).

CARE rationale
23 Dec 2019 Cash & liquid funds ₹52.26 cr
From the report

MCL also had cash and cash equivalents of Rs.52.26 crore as on September 30, 2019.

CARE rationale
19 Feb 2019 CARE reaffirmed: A+ (Stable)Rated limits ₹741.98 cr CARE rationale
19 Feb 2019 New borrowing arranged: ₹116.16 cr (term loans)
From the report

Comfortable liquidity position Liquidity position remains satisfactory as evident from healthy cash and cash equivalents of around Rs.116.16 crore as on December 31, 2018 coupled with liquidity buffer available in the form of unutilized working capital limit and undisbursed loans which are already sanctioned.

CARE rationale
19 Feb 2019 Cash & liquid funds ₹116.16 cr
From the report

Comfortable liquidity position Liquidity position remains satisfactory as evident from healthy cash and cash equivalents of around Rs.116.16 crore as on December 31, 2018 coupled with liquidity buffer available in the form of unutilized working capital limit and undisbursed loans which are already sanctioned.

CARE rationale
19 Feb 2019 Full repayment of term loan
From the report

Accordingly though the repayment of term loan is high going forward vis-à-vis expected internal generation, the comfort is derived from healthy liquidity maintained by the company.

CARE rationale
19 Feb 2019 Average working-capital utilisation 36%
From the report

Average utilization of working capital remained low at 36% during the last twelve months ended on December 31, 2018.

CARE rationale
10 Aug 2018 CARE revised: A+ (Stable)Rated limits ₹1,436.56 cr CARE rationale
10 Aug 2018 New borrowing arranged (term loans)
From the report

Outlook: Debenture Stable) Details of instruments/facilities in Annexure-1 ^ carved out of sanctioned working capital limits of the company Detailed Rationale & Key Rating Drivers The revision in the ratings assigned to Mangalam Cement Limited (MCL) factor in the moderation in the operational and financial performance of the company in FY18 (refers to period April 1 to March 31) and significant deterioration in Q1FY19.

CARE rationale
10 Aug 2018 Cash & liquid funds ₹2.54 cr
From the report

This led to an impact on PBILDT and the company incurred a cash loss of Rs2.54 crore in the quarter.

CARE rationale
06 Apr 2018 CARE other: AA- (Stable)Rated limits ₹250 cr CARE rationale
06 Apr 2018 Average working-capital utilisation 75%
From the report

In last 12 months ended January 2018, average utilisation of fund based working capital facilities of the company was around 75%.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeADITYA NAGAR, MORAK DISTT, KOTA, IN-RJ, 326520
GSTIN—
Email—
Websitehttps://www.mangalamcement.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Mangalam Cement Ltd

Competitors10identified
Locations2most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
UltraTech Cement Cement · Cement, Building Materials & Polymers ultratechcement.com 1983 Mumbai, India
Ambuja Cements Cement · Cement, Building Materials & Polymers ambujacement.com — Ahmedabad, India
ACC Cement · Cement, Building Materials & Polymers acclimited.com — Gandhinagar, India
Shree Cement Cement · Cement, Building Materials & Polymers shreecement.com — Beawar, India
Dalmia Bharat Cement · Cement, Building Materials & Polymers dalmiacement.com — Tiruchirapalli, India
JK Cement Cement · Cement, Building Materials & Polymers jkcement.com — Rajasthan, India
Nuvoco Vistas Cement · Cement, Building Materials & Polymers nuvoco.com — Mumbai, India
Birla Corporation Limited Discovered Companies · Other Industries birlacorporation.com — Kolkata, West Bengal, India
The Ramco Cements Cement · Cement, Building Materials & Polymers ramcocements.in — Rajapalayam, India
Prism Johnson Limited Tiles & Ceramics · Cement, Building Materials & Polymers prismjohnson.in — Hyderabad, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Cement

Filings

No filings on record yet.